Chicago private equity firm Madison Dearborn Partners is buying a majority interest in Walgreens Infusion Services, a subsidiary of Walgreens Boots Alliance Inc. (Nasdaq: WBA).

Walgreens Infusion Services provides home and alternate-treatment-site infusion services, including intervenous antibiotics, bleeding treatments, immunoglobulin therapy and nutrition treatment. The company has 89 infusion pharmacies and 110 alternate treatment sites in 40 states. Terms of the deal, which was announced late Jan. 20, were not disclosed.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.